Epigenetic silencing of Arginino-Succinate Synthase (Ass1) defines Arginine Depletion Therapy as a novel treatment strategy for breast cancer

F. Cavicchioli; A. Shia; K. O'Leary; V. Haley; C. Palmieri; N. Syed; T. Crook; A. M. Thompson; C. Lo Nigro; P. Schmid

doi:10.1093/annonc/mds417

Epigenetic silencing of Arginino-Succinate Synthase (Ass1) defines Arginine Depletion Therapy as a novel treatment strategy for breast cancer

F. Cavicchioli, A. Shia, K. O'Leary, V. Haley, C. Palmieri, N. Syed, T. Crook, A. M. Thompson, C. Lo Nigro, P. Schmid

Research output: Contribution to journal › Meeting abstract › peer-review

Original language	English
Article number	1660P
Pages (from-to)	532-533
Number of pages	2
Journal	Annals of Oncology
Volume	23
Issue number	S9
DOIs	https://doi.org/10.1093/annonc/mds417
Publication status	Published - 2012
Event	37th ESMO Congress Vienna, Austria, 28 September – 2 October 2012 - Vienna, Austria Duration: 28 Sept 2012 → 2 Oct 2012

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1093/annonc/mds417

Cite this

Cavicchioli, F., Shia, A., O'Leary, K., Haley, V., Palmieri, C., Syed, N., Crook, T., Thompson, A. M., Lo Nigro, C., & Schmid, P. (2012). Epigenetic silencing of Arginino-Succinate Synthase (Ass1) defines Arginine Depletion Therapy as a novel treatment strategy for breast cancer. Annals of Oncology, 23(S9), 532-533. Article 1660P. https://doi.org/10.1093/annonc/mds417

@article{6230d84686f54b9a94faa5c5703b3d99,

title = "Epigenetic silencing of Arginino-Succinate Synthase (Ass1) defines Arginine Depletion Therapy as a novel treatment strategy for breast cancer",

author = "F. Cavicchioli and A. Shia and K. O'Leary and V. Haley and C. Palmieri and N. Syed and T. Crook and Thompson, {A. M.} and {Lo Nigro}, C. and P. Schmid",

year = "2012",

doi = "10.1093/annonc/mds417",

language = "English",

volume = "23",

pages = "532--533",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Elsevier",

number = "S9",

note = "37th ESMO Congress Vienna, Austria, 28 September – 2 October 2012 ; Conference date: 28-09-2012 Through 02-10-2012",

}

TY - JOUR

T1 - Epigenetic silencing of Arginino-Succinate Synthase (Ass1) defines Arginine Depletion Therapy as a novel treatment strategy for breast cancer

AU - Cavicchioli, F.

AU - Shia, A.

AU - O'Leary, K.

AU - Haley, V.

AU - Palmieri, C.

AU - Syed, N.

AU - Crook, T.

AU - Thompson, A. M.

AU - Lo Nigro, C.

AU - Schmid, P.

PY - 2012

Y1 - 2012

U2 - 10.1093/annonc/mds417

DO - 10.1093/annonc/mds417

M3 - Meeting abstract

SN - 0923-7534

VL - 23

SP - 532

EP - 533

JO - Annals of Oncology

JF - Annals of Oncology

IS - S9

M1 - 1660P

T2 - 37th ESMO Congress Vienna, Austria, 28 September – 2 October 2012

Y2 - 28 September 2012 through 2 October 2012

ER -